BTSG FY 2025 Earnings Report — BrightSpring Health Services, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

BrightSpring Health Services, Inc. Common StockBTSG

FY 2025 Earnings

Reported February 27, 2026

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2025	Prior Q	FY 2024	QoQ Change	YoY Change
Revenue	$12.9B	—	—	—	—
Op. Income	$395M	—	—	—	—
Gross Margin	11.8%	—	—	—	—
Net Margin	1.5%	—	—	—	—
EPS (Diluted)	$0.87	—	—	—	—
Free Cash Flow	$395M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$12.9B
Cost of Revenue	$11.4B
GROSS PROFIT	$1.5B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.2B
Other Expenses	-$100M
Operating Expenses	$1.1B
Cost & Expenses	$12.5B
OPERATING INCOME	$395M
Interest Income	$0
Interest Expense	$157M
Other Income/Expenses	-$258M
INCOME BEFORE TAX	$138M
Income Tax Expense	$33M
Net Income from Continuing Ops	$105M
Net Income from Discontinued Ops	$84M
Other Adjustments	$0
NET INCOME	$191M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$191M
D&A	$164M
EBIT	$295M
EBITDA	$460M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$12.9B
Cost of Revenue	$11.4B
GROSS PROFIT	$1.5B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.2B
Other Expenses	-$100M
Operating Expenses	$1.1B
Cost & Expenses	$12.5B
OPERATING INCOME	$395M
Interest Income	$0
Interest Expense	$157M
Other Income/Expenses	-$258M
INCOME BEFORE TAX	$138M
Income Tax Expense	$33M
Net Income from Continuing Ops	$105M
Net Income from Discontinued Ops	$84M
Other Adjustments	$0
NET INCOME	$191M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$191M
D&A	$164M
EBIT	$295M
EBITDA	$460M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$191M
Depreciation & Amortization	$164M
Stock-Based Compensation	$70M
Deferred Income Tax	$0
Other Non-Cash Items	$84M
Change in Working Capital	-$19M
OPERATING CASH FLOW	$490M
Capital Expenditure	-$95M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$310M
NET CASH FROM INVESTING	-$310M
Net Debt Issuance	-$127M
Common Stock Repurchased	-$43M
Common Dividends Paid	$0
Other Financing Activities	-$8M
NET CASH FROM FINANCING	-$153M
FREE CASH FLOW	$395M
Net Change in Cash	$27M

Balance Sheet

Item	Amount
Cash & Equivalents	$88M
Short-Term Investments	$0
Net Receivables	$990M
Inventory	$815M
Other Current Assets	$1.0B
TOTAL CURRENT ASSETS	$2.9B
PP&E (Net)	$376M
Goodwill	$2.5B
Intangible Assets	$558M
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$40M
TOTAL NON-CURRENT ASSETS	$3.5B
TOTAL ASSETS	$6.4B
Account Payables	$1.2B
Short-Term Debt	$102M
Deferred Revenue	$0
Other Current Liabilities	$529M
TOTAL CURRENT LIABILITIES	$1.8B
Long-Term Debt	$2.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$6M
Other Non-Current Liabilities	-$69M
TOTAL NON-CURRENT LIABILITIES	$2.7B
TOTAL LIABILITIES	$4.5B
Common Stock	$2M
Additional Paid-In Capital	$2.0B
Retained Earnings	-$75M
Treasury Stock	$0
Accum. Other Comp. Income	-$7M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.9B
Minority Interest	$11M
TOTAL EQUITY	$1.9B
TOTAL LIABILITIES & EQUITY	$6.4B
Total Debt	$2.8B
Net Debt	$2.8B